Cardiovascular manifestations in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS)
Authors:
Stará Veronika
Authors place of work:
Pediatrická klinika 2. LF UK a FN v Motole, Praha
Published in the journal:
Čes-slov Pediat 2022; 77 (1): 39-42.
Category:
Summary
COVID-19-associated multisystem inflammatory response syndrome in children (PIMS-TS) is a rare complication of SARS-CoV-2 infection in children, and cardiovascular involvement is a significant factor in the morbidity of this disease. Cardiovascular complications include left ventricular dysfunction, coronary artery dilatations or aneurysms, rhythm disturbances, pericarditis and valvulitis. In some patients, the disease may present with shock, and thromboembolic events may also be a serious complication. The key diagnostic methods for cardiovascular complications in PIMS-TS are transthoracic echocardiography and electrocardiography. Although most patients experience complete restitution of cardiac function with adequate treatment, patients should undergo regular cardiac follow-up during the first year after the disease.
Keywords:
echocardiography – Aneurysms – systolic dysfunction – follow up
Zdroje
1. Alsaied T, et al. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. Circulation 2021; 143(1): 78–88. doi: 10.1161/CIRCULATIONA - HA.120.049836.
2. Sperotto F, et al. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammator syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr 2021; 180: 307–322.
3. Yasuhara J, et al. COVID-19 and multisystem inflammatory syndrome in children: A systematic review and meta-analysis. Pediatr Pulmonol 2021. Dostupné na: https://onlinelibrary. wiley.com/doi/10.1002/ppul.25245.
4. Belhadjer Z, et al. Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-Pandemic. Circulation 2020; 142(5): 429– 436.
5. Choi NH, et al. MIS-C and Cardiac Conduction Abnormalities. Pediatrics 2020; 146(6): e2020009738. doi: 10.1542/ peds.2020-009738.
6. Ahmed M, et al. Multisystem inflammatory syndrome in children: A systematic review. Clin Med 2020; 26: 100527.
7. McCrindle BW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation 2017; 135: e927–e999.
8. Fencl F, et al. Syndrom multisystémové zánětlivé odpovědi asociovaný s COVID-19 u dětí. Doporučený postup ČPS ČLS JEP. Ces Slov Pediatr 2021; 76(1): 4–9.
Štítky
Neonatology Paediatrics General practitioner for children and adolescentsČlánok vyšiel v časopise
Czech-Slovak Pediatrics
2022 Číslo 1
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis
Najčítanejšie v tomto čísle
- Laboratory newborn screening
- Differential diagnosis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2
- Z historie pediatrie
- Brief overview of child and adolescent psychopharmacotherapy